JP2000516946A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000516946A5 JP2000516946A5 JP1998511337A JP51133798A JP2000516946A5 JP 2000516946 A5 JP2000516946 A5 JP 2000516946A5 JP 1998511337 A JP1998511337 A JP 1998511337A JP 51133798 A JP51133798 A JP 51133798A JP 2000516946 A5 JP2000516946 A5 JP 2000516946A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR96/10528 | 1996-08-28 | ||
| FR9610528A FR2752732B1 (fr) | 1996-08-28 | 1996-08-28 | Forme galenique a liberation prolongee de milnacipran |
| PCT/FR1997/001525 WO1998008495A1 (fr) | 1996-08-28 | 1997-08-26 | Forme galenique a liberation prolongee de milnacipran |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010053612A Division JP5431214B2 (ja) | 1996-08-28 | 2010-03-10 | ミルナシプランの持続性放出を伴うガレヌス製剤形態 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2000516946A JP2000516946A (ja) | 2000-12-19 |
| JP2000516946A5 true JP2000516946A5 (enExample) | 2005-04-07 |
| JP4549442B2 JP4549442B2 (ja) | 2010-09-22 |
Family
ID=9495256
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51133798A Expired - Lifetime JP4549442B2 (ja) | 1996-08-28 | 1997-08-26 | ミルナシプランの持続性放出を伴うガレヌス製剤形態 |
| JP2010053612A Expired - Lifetime JP5431214B2 (ja) | 1996-08-28 | 2010-03-10 | ミルナシプランの持続性放出を伴うガレヌス製剤形態 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010053612A Expired - Lifetime JP5431214B2 (ja) | 1996-08-28 | 2010-03-10 | ミルナシプランの持続性放出を伴うガレヌス製剤形態 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6699506B1 (enExample) |
| EP (1) | EP0939626B1 (enExample) |
| JP (2) | JP4549442B2 (enExample) |
| CN (1) | CN1108791C (enExample) |
| AT (1) | ATE213629T1 (enExample) |
| AU (1) | AU727018B2 (enExample) |
| BR (1) | BR9711378A (enExample) |
| CA (1) | CA2264238C (enExample) |
| DE (1) | DE69710757T2 (enExample) |
| DK (1) | DK0939626T3 (enExample) |
| ES (1) | ES2171991T3 (enExample) |
| FR (1) | FR2752732B1 (enExample) |
| PT (1) | PT939626E (enExample) |
| WO (1) | WO1998008495A1 (enExample) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19928312A1 (de) * | 1999-06-16 | 2000-12-21 | Schering Ag | Arzneimittelzubereitung mit verzögerter Wirkstoffabgabe |
| US8101209B2 (en) * | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| FR2830447B1 (fr) * | 2001-10-09 | 2004-04-16 | Flamel Tech Sa | Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques |
| US6635675B2 (en) | 2001-11-05 | 2003-10-21 | Cypress Bioscience, Inc. | Method of treating chronic fatigue syndrome |
| US6602911B2 (en) | 2001-11-05 | 2003-08-05 | Cypress Bioscience, Inc. | Methods of treating fibromyalgia |
| CA2480824A1 (fr) * | 2002-04-09 | 2003-10-16 | Flamel Technologies | Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee d'amoxicilline |
| PT1492511E (pt) | 2002-04-09 | 2009-04-09 | Flamel Tech Sa | Formulação farmacêutica oral na forma de suspensão aquosa de microcápsulas para libertação modificada de princípio(s) activo(s) |
| US20040132826A1 (en) * | 2002-10-25 | 2004-07-08 | Collegium Pharmaceutical, Inc. | Modified release compositions of milnacipran |
| JP2006506461A (ja) * | 2002-10-25 | 2006-02-23 | コルジウム ファーマシューティカル， インコーポレイテッド | ミルナシプランのパルス型放出組成物 |
| US20060024366A1 (en) * | 2002-10-25 | 2006-02-02 | Collegium Pharmaceutical, Inc. | Modified release compositions of milnacipran |
| US7704527B2 (en) * | 2002-10-25 | 2010-04-27 | Collegium Pharmaceutical, Inc. | Modified release compositions of milnacipran |
| US20060003004A1 (en) * | 2002-10-25 | 2006-01-05 | Collegium Pharmaceutical, Inc. | Pulsatile release compositions of milnacipran |
| EP1592453A1 (en) * | 2003-01-28 | 2005-11-09 | Collegium Pharmaceutical, Inc. | Multiparticulate compositions of milnacipran for oral administration |
| FR2851163B1 (fr) * | 2003-02-14 | 2007-04-27 | Utilisation de l'enantiomere dextrogyre du milnacipran pour la preparation d'un medicament | |
| PT1601349E (pt) * | 2003-02-14 | 2008-10-27 | Pf Medicament | Utilização do enantiómero (1s, 2r) do milnaciprano para a preparação de um medicamento |
| WO2006132307A1 (ja) | 2005-06-10 | 2006-12-14 | Pierre Fabre Medicament S.A. | 安定化されたミルナシプラン製剤 |
| US7994220B2 (en) | 2005-09-28 | 2011-08-09 | Cypress Bioscience, Inc. | Milnacipran for the long-term treatment of fibromyalgia syndrome |
| US20080319083A1 (en) * | 2006-01-27 | 2008-12-25 | Asahi Kasei Pharma Corporation | Medicine for transnasal administration |
| WO2008109462A2 (en) * | 2007-03-02 | 2008-09-12 | Farnam Companies, Inc. | Sustained release pellets comprising wax-like material |
| CN101301283B (zh) * | 2007-05-10 | 2011-04-06 | 上海医药工业研究院 | 一种米那普仑的经鼻脑转运组合物 |
| EP2110129A1 (en) | 2008-04-18 | 2009-10-21 | Pierre Fabre Medicament | Use of enantiomer (1S, 2R) milnacipran hydrochloride for the preventive treatment of suicidal behaviour in depressed patients |
| ES2536736T3 (es) * | 2008-09-04 | 2015-05-28 | Farnam Companies, Inc. | Formulaciones masticables de liberación sostenida |
| EP2448406B1 (en) | 2009-02-26 | 2016-04-20 | Relmada Therapeutics, Inc. | Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use |
| US20100239681A1 (en) * | 2009-03-20 | 2010-09-23 | Biokey, Inc. | Controlled Release Particulates Containing Water-Insoluble Drug |
| FR2943546A1 (fr) * | 2009-03-31 | 2010-10-01 | Nouveaux Produits Pharma Sas | Excipient pharmaceutique fonctionnalise ameliorant la biodisponibilite de substances actives peu solubles, microgranules l'incorporant. |
| FR2945449B1 (fr) | 2009-05-15 | 2012-10-05 | Pf Medicament | Procede d'impregnation par co2 supercritique |
| US9173845B2 (en) | 2009-08-05 | 2015-11-03 | Lupin Limited | Controlled release pharmaceutical compositions of milnacipran |
| JP2013510176A (ja) | 2009-11-06 | 2013-03-21 | ピエール ファーブル メディカモン | （１ｓ，２ｒ）−２−（アミノメチル）−ｎ，ｎ−ジエチル−１−フェニルシクロプロパンカルボキサミドの新規結晶形態 |
| WO2011088331A1 (en) * | 2010-01-14 | 2011-07-21 | Forest Laboratories Holdings Limited | Stable dosage forms of levomilnacipran |
| WO2011107921A2 (en) | 2010-03-04 | 2011-09-09 | Ranbaxy Laboratories Limited | Modified release composition of milnacipran |
| WO2011107922A2 (en) | 2010-03-04 | 2011-09-09 | Ranbaxy Laboratories Limited | Extended release composition of milnacipran |
| US8916194B2 (en) | 2010-08-30 | 2014-12-23 | Lupin Limited | Controlled release pharmaceutical compositions of milnacipran |
| FR2978350B1 (fr) | 2011-07-28 | 2013-11-08 | Pf Medicament | Medicament a base de levomilnacipran pour la rehabilitation fonctionnelle apres accident neurologique aigu |
| CN102793683B (zh) * | 2012-09-04 | 2013-04-17 | 海南康虹医药科技开发有限公司 | 一种含左旋米那普仑的缓释组合物及其制备方法 |
| WO2014078435A1 (en) | 2012-11-14 | 2014-05-22 | W. R. Grace & Co.-Conn. | Compositions containing a biologically active material and a non-ordered inorganic oxide |
| JP6186139B2 (ja) * | 2013-03-08 | 2017-08-23 | 杏林製薬株式会社 | 口腔内速崩壊性錠剤 |
| CN105769823A (zh) * | 2014-12-24 | 2016-07-20 | 上海星泰医药科技有限公司 | 一种左旋盐酸米那普仑缓释胶囊及其制备方法 |
| EP3167879A1 (en) * | 2015-11-10 | 2017-05-17 | Evonik Technochemie GmbH | Gastric retention active delivery systems |
| CN110711185A (zh) * | 2018-07-11 | 2020-01-21 | 北京万全德众医药生物技术有限公司 | 左旋米那普仑缓释胶囊 |
| JP7315383B2 (ja) * | 2019-06-27 | 2023-07-26 | 株式会社Ｓｃｒｅｅｎホールディングス | インクジェット用水性組成物及び固体製剤 |
| CN114569566A (zh) * | 2020-12-02 | 2022-06-03 | 四川科瑞德制药股份有限公司 | 一种盐酸米那普仑制剂的制备方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2508035A1 (fr) * | 1981-06-23 | 1982-12-24 | Fabre Sa Pierre | Derives d'aryl-1-aminomethyl-2 cyclopropanes carboxamides (z), leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central |
| JPS58180481A (ja) | 1982-04-15 | 1983-10-21 | Kyowa Hakko Kogyo Co Ltd | 新規なピペリジン誘導体 |
| FR2581059B1 (fr) * | 1985-04-25 | 1988-04-22 | Pf Medicament | Procede de preparation du chlorhydrate de phenyl-1 diethyl amino carbonyl-1 aminomethyl-2 cyclopropane (z) |
| FR2581060B1 (fr) * | 1985-04-25 | 1988-07-01 | Pf Medicament | Procede industriel d'obtention du midalcipran |
| US5026560A (en) * | 1987-01-29 | 1991-06-25 | Takeda Chemical Industries, Ltd. | Spherical granules having core and their production |
| FI95572C (fi) | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
| FR2640972B1 (enExample) * | 1988-12-28 | 1991-04-19 | Pf Medicament | |
| CA2007181C (en) * | 1989-01-06 | 1998-11-24 | Angelo Mario Morella | Sustained release pharmaceutical composition |
| JP2807577B2 (ja) | 1990-06-15 | 1998-10-08 | エーザイ株式会社 | 環状アミド誘導体 |
| FR2677019B1 (fr) | 1991-05-27 | 1994-11-25 | Pf Medicament | Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique. |
| GB9113872D0 (en) * | 1991-06-27 | 1991-08-14 | Sandoz Ag | Improvements in or relating to organic compounds |
| US5160742A (en) * | 1991-12-31 | 1992-11-03 | Abbott Laboratories | System for delivering an active substance for sustained release |
| ES2141763T3 (es) | 1992-03-31 | 2000-04-01 | Glaxo Group Ltd | Fenilcarbonatos y fenilureas sustituidos, su preparacion y su uso como antagonistas de 5-ht4. |
| EP0650353B1 (en) * | 1992-06-04 | 2002-05-22 | Smithkline Beecham Corporation | Palatable pharmaceutical compositions |
| CA2134038C (en) * | 1994-06-16 | 1997-06-03 | David Taiwai Wong | Potentiation of drug response |
| US5910319A (en) * | 1997-05-29 | 1999-06-08 | Eli Lilly And Company | Fluoxetine enteric pellets and methods for their preparation and use |
-
1996
- 1996-08-28 FR FR9610528A patent/FR2752732B1/fr not_active Expired - Fee Related
-
1997
- 1997-08-26 JP JP51133798A patent/JP4549442B2/ja not_active Expired - Lifetime
- 1997-08-26 AT AT97938949T patent/ATE213629T1/de active
- 1997-08-26 PT PT97938949T patent/PT939626E/pt unknown
- 1997-08-26 CN CN97198442A patent/CN1108791C/zh not_active Expired - Lifetime
- 1997-08-26 CA CA002264238A patent/CA2264238C/fr not_active Expired - Lifetime
- 1997-08-26 AU AU41212/97A patent/AU727018B2/en not_active Expired
- 1997-08-26 US US09/254,014 patent/US6699506B1/en not_active Expired - Lifetime
- 1997-08-26 DK DK97938949T patent/DK0939626T3/da active
- 1997-08-26 DE DE69710757T patent/DE69710757T2/de not_active Expired - Lifetime
- 1997-08-26 WO PCT/FR1997/001525 patent/WO1998008495A1/fr not_active Ceased
- 1997-08-26 BR BR9711378A patent/BR9711378A/pt not_active Application Discontinuation
- 1997-08-26 EP EP97938949A patent/EP0939626B1/fr not_active Expired - Lifetime
- 1997-08-26 ES ES97938949T patent/ES2171991T3/es not_active Expired - Lifetime
-
2010
- 2010-03-10 JP JP2010053612A patent/JP5431214B2/ja not_active Expired - Lifetime